UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Keep-ING balance: Tumor suppression by epigenetic regulation

FEBS letters, 2014-08, Vol.588 (16), p.2728-2742

2014

Volltextzugriff (PDF)

Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

Journal of clinical oncology, 2010-05, Vol.28 (14), p.2339-2347

2010

Volltextzugriff (PDF)

The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination

PloS one, 2011-06, Vol.6 (6), p.e21065-e21065

2011

Volltextzugriff (PDF)

Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylation

Molecular cancer therapeutics, 2010-02, Vol.9 (2), p.480-488

2010

Volltextzugriff (PDF)

DisorderING promotes epigenetic order

FEBS letters, 2017-01, Vol.591 (2), p.257-259

2017

Volltextzugriff (PDF)

Die Leitsymptome im Überblick

Pädiatrie : Kinder- und Jugendmedizin hautnah, 2015-12, Vol.27 (6), p.28-34

2015

Volltextzugriff (PDF)

Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group

European journal of cancer (1990), 2011-01, Vol.47 (1), p.90-97

2011

Volltextzugriff (PDF)

Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death

Journal of neuro-oncology, 2008-01, Vol.86 (1), p.23-30

2008

Volltextzugriff (PDF)

Clinical significance of cytogenetic changes in childhood T-cell acute lymphoblastic leukemia: results of the multicenter group Moscow-Berlin (MB)

Leukemia & lymphoma, 2019-01, Vol.60 (2), p.426-432

2019

Volltextzugriff (PDF)

Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries

Memo - Magazine of European medical oncology, 2013-02, Vol.6 (1), p.5-8

2013

Volltextzugriff (PDF)

Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002

Journal of cancer research and clinical oncology, 2019-04, Vol.145 (4), p.1001-1012

2019

Volltextzugriff (PDF)

Deliberations about clinical pharmacogenetic testing in pediatric oncology

Personalized medicine, 2021-07, Vol.18 (4), p.399-405

2021

Volltextzugriff (PDF)

Strategies to improve the quality of survival for childhood brain tumour survivors

European journal of paediatric neurology, 2015-11, Vol.19 (6), p.619-639

2015

Volltextzugriff (PDF)

The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1

PloS one, 2011-06, Vol.6 (6), p.e21065

2011

Volltextzugriff (PDF)

The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells

Oncology research, 2010-01, Vol.18 (10), p.469-480

2010

Volltextzugriff (PDF)

Novel Pt(II) anticancer agents and their Pd(II) analogues: syntheses, crystal structures, reactions with nucleobases and cytotoxicities

Inorganica Chimica Acta, 2001-07, Vol.319 (1), p.109-116

2001

Volltextzugriff (PDF)

No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma

International journal of cancer, 2004-04, Vol.109 (3), p.476-479

2004

Volltextzugriff (PDF)

The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells

Oncology research, 2009-01, Vol.18 (2-3), p.95-105

2009

Volltextzugriff (PDF)

The cancer-aging interface and the significance of telomere dynamics in cancer therapy

Rejuvenation research, 2007-09, Vol.10 (3), p.387-396

2007

Volltextzugriff (PDF)

Pdgfr‐α in 1p/19q LOH oligodendrogliomas

International journal of cancer, 2004-12, Vol.112 (6), p.1081-1082

2004

Volltextzugriff (PDF)

Behandlung von Kindern und Jugendlichen mit Rezidiv einer ALL: Therapieziel langfristige Heilung

Pharmazie in unserer Zeit, 2012-05, Vol.41 (3), p.214-221

2012

Volltextzugriff (PDF)

Treatment of children and adolescents with relapsed ALL: therapy target long-term healing

Pharmazie in unserer Zeit, 2012-05, Vol.41 (3), p.214-221

2012

Volltextzugriff (PDF)

Chapter 27 - Epigenetic regulation of the cell cycle & DNA-repair in cancer

Genome Stability, 2021, p.521-531

Second Edition, 2021

Volltextzugriff (PDF)

Epigenetically decipherING the genome: A role for PHDs

Chromatin Readers in Health and Disease, 2023, Vol.35

Binda, Olivier

2023

Volltextzugriff (PDF)

Diagnostics and Diagnosis of Late Effects in Childhood Brain Tumour Survivors

Late Treatment Effects and Cancer Survivor Care in the Young, 2021, p.239-251

2021

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(28)
Buchkapitel
(3)

Sprache

Englisch
(29)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(17)
Science & Technology
(17)
Life Sciences & Biomedicine
(14)
Oncology
(9)
Child
(8)
Adolescent
(6)
Cell Line, Tumor
(5)
Female
(5)
Gene Expression Regulation, Neoplastic
(5)
Inhibitor Of Growth Protein 1
(5)
Male
(5)
Neurology
(5)
Tumors
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Biological And Medical Sciences
(4)
Child, Preschool
(4)
Medical Sciences
(4)
Acetylation
(3)
Animals
(3)
Apoptosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Keep-ING balance: Tumor suppression by epigenetic regulation

Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination

Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylation

DisorderING promotes epigenetic order

Die Leitsymptome im Überblick

Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group

Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death

Clinical significance of cytogenetic changes in childhood T-cell acute lymphoblastic leukemia: results of the multicenter group Moscow-Berlin (MB)

Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries

Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002

Deliberations about clinical pharmacogenetic testing in pediatric oncology

Strategies to improve the quality of survival for childhood brain tumour survivors

The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1

The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells

Novel Pt(II) anticancer agents and their Pd(II) analogues: syntheses, crystal structures, reactions with nucleobases and cytotoxicities

No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma

The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells

The cancer-aging interface and the significance of telomere dynamics in cancer therapy

Pdgfr‐α in 1p/19q LOH oligodendrogliomas

Behandlung von Kindern und Jugendlichen mit Rezidiv einer ALL: Therapieziel langfristige Heilung

Treatment of children and adolescents with relapsed ALL: therapy target long-term healing

Chapter 27 - Epigenetic regulation of the cell cycle & DNA-repair in cancer

Epigenetically decipherING the genome: A role for PHDs

Diagnostics and Diagnosis of Late Effects in Childhood Brain Tumour Survivors

Suchergebnisse filtern